Article Details
Retrieved on: 2022-06-16 18:33:08
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
22nd Century Group Inc. has sold enough company stock to purchase privately held GVB Biopharma in a deal valued overall at $55 million.
Article found on: journalnow.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here